Hepatitis C (HCV) Research Samples
12 Results
1 - 12 of 12 total samples.
Advanced Data View:
1 - 12 of 12 total samples.
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test 1 Result | Test 1 Detail | Test 2 | Test 2 Result | Test 3 | Test 3 Result | Product Details | Price | Buy | Fujirebio INNO-LIA HCV Score | HCV Serology Vitros 3600 | Genotype | Roche cobas c 4800 System (viral load) | IRB Approval ID |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BF19873795 | Hepatitis C (HCV) | Europe | Plasma CPD | 1.00 | 3.00 | $350.00 | Y | U/A | U/A | <-70C | 30-Jan-24 | Roche cobas Elecsys Anti-HCV II | 32.6 (Positive) | Hepatitis C (HCV) | Abbott ARCHITECT Anti-HCV | 19.4 (Positive) | Roche cobas MPX | Positive | $350.00 | C1(3+); C2(2+); E2(1+); NS3(4+); NS4(3+); NS5(2+) | 28.2 | 4a | 2790000 IU/mL 6.45 Log 10 | ||||
| BF19873796 | Hepatitis C (HCV) | Europe | Plasma CPD | 1.00 | 5.00 | $350.00 | Y | U/A | U/A | <-70C | 02-Jul-24 | Roche cobas Elecsys Anti-HCV II | 7.62 (Positive) | Hepatitis C (HCV) | Abbott ARCHITECT Anti-HCV | 16.69 (Positive) | Roche cobas MPX | Positive | $350.00 | C1(3+); C2(3+); E2(1+); NS3(4+); NS4(3+); NS5(3+) | 20.5 | 3a | 1260000 IU/mL 6.1 Log 10 | ||||
| BF19873797 | Hepatitis C (HCV) | Europe | Plasma CPD | 1.00 | 5.00 | $350.00 | Y | U/A | U/A | <-70C | 17-Dec-24 | Roche cobas Elecsys Anti-HCV II | 54.1 (Positive) | Hepatitis C (HCV) | Abbott ARCHITECT Anti-HCV | 20.6 (Positive) | Roche cobas MPX | Positive | $350.00 | C1(3+); C2(3+); E2(1+); NS3(3+); NS4(3+); NS5(--) | 28.6 | 4d | 472000 IU/mL 5.67 Log 10 | ||||
| BF19873798 | Hepatitis C (HCV) | Europe | Plasma CPD | 1.00 | 4.00 | $350.00 | Y | U/A | U/A | <-70C | 06-Nov-24 | Roche cobas Elecsys Anti-HCV II | 38.7 (Positive) | Hepatitis C (HCV) | Abbott ARCHITECT Anti-HCV | 18.89 (Positive) | Roche cobas MPX | Positive | $350.00 | C1(2+); C2(2+); E2(2+); NS3(4+); NS4(3+); NS5(--) | 26.8 | 4k | 2450000 IU/mL 6.39 Log 10 | ||||
| BF19873799 | Hepatitis C (HCV) | Europe | Plasma CPD | 1.00 | 5.00 | $350.00 | Y | U/A | U/A | <-70C | 19-Mar-24 | Roche cobas Elecsys Anti-HCV II | 139 (Positive) | Hepatitis C (HCV) | Abbott ARCHITECT Anti-HCV | 17.19 (Positive) | Roche cobas MPX | Positive | $350.00 | C1(4+); C2(3+); E2(2+); NS3(2+); NS4(--); NS5(--) | 28 | 5a | 2600000 IU/mL 6.41 Log 10 | ||||
| KH25-01437 | Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $250.00 | 1 M | M | White | <-70C | 04-Mar-25 | Abbott Alinity HCV | 8.98 (Reactive) S/Co | Hepatitis C (HCV) Ab | $250.00 | 45469786 | |||||||||||
| KH26-00580 | Hepatitis C (HCV) | USA | Serum | 1.25 | 1.00 | $400.00 | 60 Y | M | White | <-70C | 01-May-26 | Roche cobas RNA Qt | 672000 IU/mL | Hepatitis C (HCV) | Genotype | 1a or 1b | $400.00 | 45469786 | |||||||||
| KH26-00650 | Hepatitis C (HCV) | USA | Serum | 1.75 | 1.00 | $400.00 | 54 Y | M | White | <-70C | 07-May-26 | Roche cobas RNA Qt | 135000 IU/mL | Hepatitis C (HCV) | Genotype | 1a or 1b | $400.00 | 45469786 | |||||||||
| KH26-02293 | Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $400.00 | 66 Y | M | White | <-70C | 28-Apr-26 | Roche cobas RNA Qt | 19 IU/mL | Hepatitis C (HCV) | Genotype | 1a or 1b | $400.00 | 45469786 | |||||||||
| KH26-02456 | Hepatitis C (HCV) | USA | Serum | 1.50 | 1.00 | $400.00 | 71 Y | M | White | <-70C | 14-May-26 | Roche cobas RNA Qt | 5730000 IU/mL | Hepatitis C (HCV) | Genotype | 1a or 1b | $400.00 | 45469786 | |||||||||
| KH26-04601 | Hepatitis C (HCV) | USA | Serum | 1.50 | 1.00 | $400.00 | 37 Y | F | White | <-70C | 29-Jul-26 | Roche cobas RNA Qt | 160,000 | Hepatitis C (HCV) | Genotype | 1a or 1b | $400.00 | 45469786 | |||||||||
| KH26-06219 | Hepatitis C (HCV) | USA | Serum | 1.50 | 1.00 | $400.00 | 62 Y | M | White | <-70C | 13-Aug-26 | Roche cobas RNA Qt | 1,060,000 | Hepatitis C (HCV) | Genotype | 2B | S/CO | 15.75 | $400.00 | 45469786 |